UK's MHRA issues draft guidance on neurostimulators
This article was originally published in Clinica
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency has issued draft guidance for manufacturers of neurostimulators, giving advice on reporting of adverse incidents involving their products under the Medical Devices Vigilance System.